ACE2 and colorectal cancer: To investigate the cause of the upregulated expression in colorectal cancer, we analyzed the DNA copy number variation of ACE2 and TMPRSS2. There were less than 1% patients with ACE2 amplification, and no patient had TMPRSS2 amplification in colorectal cancer (Figure 2A).